[ESPR] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
08-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -6.90%
YoY- -208.78%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 212,236 982 0 0 0 0 0 -
PBT 124,611 -54,221 -45,730 -43,337 -14,035 -12,395 -9,238 -
Tax 4,721 0 0 433 494 337 18 152.78%
NP 124,611 -54,221 -45,730 -43,337 -14,035 -12,395 -9,238 -
Tax Rate -3.79% - - - - - - -
Total Cost 87,625 55,203 45,730 43,337 14,035 12,395 9,238 45.44%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 58.71 -5,521.49 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 4.50 -2.01 -1.71 -1.92 -0.62 -0.55 -0.60 -
EPS Diluted 4.32 -2.01 -1.71 -1.92 -0.62 -0.55 -0.60 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.